Seattle Genetics | SGEN - DÍVIDA



DÍVIDA Alterar Data
AbbVie USD 72.86B 5.36B 2026-03
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Amgen USD 57.32B 2.72B 2026-03
Astellas Pharma JPY 565.95B 265.47B 2026-03
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Celldex Therapeutics USD 1.91M 428K 2026-03
Daiichi Sankyo JPY 300.48B 99.34B 2026-03
Eisai JPY 186.08B 50.58B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Exelixis USD 165.93M 3.61M 2026-06
Genmab DKK 5.35B 5.2B 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Incyte USD 38.27M 1.16M 2026-06
Insmed USD 725.8M 1.82M 2026-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 36.51M 500K 2026-03
Merck USD 49.12B 222M 2026-03
Moderna USD 1.3B 7M 2026-03
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Takeda JPY 4.94T 58.13B 2026-06
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06
Xencor USD 175.16M 12.58M 2026-03